Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: Differential regulation of insulin signaling pathways

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Palsgaard, Jane ^a   Brøns, Charlotte ^b   Friedrichsen, Martin ^b   Dominguez, Helena ^b   Jensen, Maja ^a   Storgaard, Heidi ^b   Spohr, Camilla ^b   Torp Pedersen, Christian ^b   Borup, Rehannah ^c   De Meyts, Pierre ^a   Vaag, Allan ^b  

^a HAGEDORN RESEARCH INSTITUTE   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; HEXOKINASE; HEXOKINASE 2; HISTONE DEACETYLASE; INSULIN; INSULIN RECEPTOR; KINESIN; KINESIN FAMILY MEMBER 1B; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME 1; LIPOPROTEIN LIPASE; MYOSTATIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHORYLASE KINASE; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN GENOME; HUMAN TISSUE; INSULIN RESISTANCE; MALE; MICROARRAY ANALYSIS; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE PHOSPHORYLATION; RISK FACTOR; SIBLING RELATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; UPREGULATION; BIOPSY; CASE CONTROL STUDY; GENETICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; BIOPSY; BLOTTING, WESTERN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION PROFILING; HUMANS; INSULIN; MALE; MUSCLE, SKELETAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 68949122307     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006575     Document Type: Article

References (36)

1. Elbein SC (2000) Genetics of type 2 diabetes: an overview for the millennium. Diabetes technology & therapeutics 2: 391-400.
2. Jackson S, Bagstaff SM, Lynn S, Yeaman SJ, Turnbull DM, et al. (2000) Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families. Diabetes 49: 1169-1177.
3. Thompson DB, Pratley R, Ossowski V (1996) Human primary myoblast cell cultures from non-diabetic insulin resistant subjects retain defects in insulin action. J Clin Invest 98: 2346-2350.
4. Hansen L, Gaster M, Oakeley EJ, Brusgaard K, Damsgaard-Nielsen EM, et al. (2004) Expression profiling of insulin action in human myotubes: induction of inflammatory and pro-angiogenic pathways in relationship with glycogen synthesis and type 2 diabetes. Biochem Biophys Res Commun 323: 685-695.
5. Jafar-Mohammadi B, McCarthy M (2007) Genetics of type 2 diabetes mellitus and obesity - a review. Ann Med1-9.
6. Kahn CR (1994) Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: 1066-1084.
7. De Meyts P (1993) The diabetogenes concept of NIDDM. Adv Exp Med Biol 334: 89-8100.
8. Sladek R, Rocheleau G, Rung J, Dina C, Shen C, et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445: 881-885.
9. Frayling TM (2007) Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8: 657-662.
10. Zeggini E, Scott LJ, Saxena R, Voight BF (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nature Genetics 40: 638-645.
11. Staiger H, Machicao F, Stefan N, Tschritter O, Thamer C, et al. (2007) Polymorphisms within novel risk loci for type 2 diabetes determine β-cell function. PLoS ONE 9: e832.
12. Bjornholm M, Zierath JR (2005) Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes. Biochem Soc Trans 33: 354-357.
13. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273.
14. Patti ME, Butte AJ, Crunkhorn S (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100: 8466-8471.
15. Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS (2002) Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51: 1913-1920.
16. McIntyre EA, Walker M (2002) Genetics of type 2 diabetes and insulin resistance: knowledge from human studies. Clin Endocrinol (Oxf) 57: 303-311.
17. Karlsson HK, Ahlsén M, Zierath JR, Wallberg-Henriksson H, Koistinen HA (2006) Insulin signaling and glucose transport in skeletal muscle from first-degree relatives of type 2 diabetic patients. Diabetes 55: 1283-1288.
18. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
19. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
20. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR (2003) MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biology 4: R7.
21. Vaag A, Henriksen JE, Beck-Nielsen H (1992) Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89: 782-788.
22. Ducluzeau PH, Perretti N, Laville M, Andreelli F, Vega N, et al. (2001) Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes. Diabetes 50: 1134-1142.
23. Mercado MM, McLenithan JC, Silver KD, Shuldiner AR (2002) Genetics of insulin resistance. Curr Diab Rep 2: 83-95.
24. Zierath JR, Wallberg-Henriksson H (2002) From receptor to effector: insulin signal transduction in skeletal muscle from type II diabetic patients. Ann NY Acad Sci 967: 120-134.
25. Nangaku M, Sato-Yoshitake R, Okada Y, Noda Y, Takemura R, et al. (1994) KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell 79: 1209-1220.
26. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, et al. (2001) Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105: 587-597.
27. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsøe R, et al. (2007) Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50: 790-796.
28. Barazzoni R, Zanetti M, Bosutti A, Stebel M, Cattin L, et al. (2004) Myostatin expression is not altered by insulin deficiency and replacement in streptozotocin-diabetic rat skeletal muscles. Clin Nutr 23: 1413-1417.
29. Joulia-Ekaza D, Cabello G (2007) The myostatin gene: physiology and pharmacological relevance. Curr Opin Pharmacol 7: 310-315.
30. Tsuchida K (2004) Activins, myostatin and related TGF-beta family members as novel therapeutic targets for endocrine, metabolic and immune disorders. Curr Drug Targets Immune Endocr Metabol Disord 4: 157-166.
31. Petersen KF, Dufour S, Shulman GI (2005) Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Medicine 2: e233.
32. Rabøl R, Boushel R, Dela F (2006) Mitochondrial oxidative function and type 2 diabetes. Appl Physiol Nutr Metab 31: 675-683.
33. Vestergaard H, Bjørbæk C, Hansen T, Larsen FS, Granner DK, et al. (1995) Impaired activity and gene expression of hexokinase II in muscle from noninsulin-dependent diabetes mellitus patients. J Clin Invest 96: 2639-2645.
34. Pendergrass M, Koval J, Vogt C, Yki-Jarvinen H, Lozzo P, et al. (1998) Insulin-induced hexokinase II expression is reduced in obesity and NIDDM. Diabetes 47: 387-394.
35. Gray SG, De Meyts P (2005) Role of histone and transcription factor acetylation in diabetes pathogenesis. Diabetes Metab Res Rev 21: 416-433.
36. Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. Journal of applied physiology: respiratory, environmental and exercise physiology 55: 628-634.